News

Today, it is a key tool in preventing heart attacks and strokes. A recent study presented at the SLEEP 2024 conference in ...
The U.S. Food and Drug Administration approved changing the prescribing information for Eli Lilly's Alzheimer's drug Kisunla to allow more gradual dosing to lower the risk of a potentially dangerous ...